CDKL2-IN-1

CDK-IN-14 (Compound 9) serves as a potent and selective inhibitor of CDKL2 (Cyclin-dependent kinase-like 2), exhibiting an IC50 of 460 nM. Linked to biological processes such as tumor formation, development, and viral infections, CDKL2 is a substantial focus in the field. CDK-IN-14 holds promise as a powerful tool for the exploration of CDKL2s biological functions, potentially advancing research in areas like cancer and infectious diseases.